Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Placebo analgesia

Full Text:


Placebos are drugs, devices, or other treatments that are physically and pharmacologically inert. The placebo effects are therapeutic responses to the context of the treatment process. They are mediated by factors, such as training of a patient, his/her expectations associated with treatment, as well as social conditions, the features of cognitive functioning, etc. and can affect the clinical and physiological responses caused by the health status. The analgesic effects of placebo in different types of pain syndromes reach 25–80%. The formation of placebo analgesia involves the brain structures that belong to the pain matrix and are implicated in the basic processes of perception, in the mechanisms of pain modulation, and in a number of other cognitive and affective processes, as well as in the emotional reactions not caused by pain. A deeper understanding of the mechanisms of action of placebo analgesia can optimize the strategy of current pain therapy.

About the Author

G. R. Tabeeva
I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow
Russian Federation
Department of Nervous System Diseases and Neurosurgery, Faculty of General Medicine


1. Benedetti F. Placebo effects: from the neurobiological paradigm to translational implications. Neuron. 2014 Nov 5;84(3):623-37. doi: 10.1016/j.neuron.2014.10.023. Epub 2014 Nov 5.

2. Meissner K. The placebo effect and the autonomic nervous system: evidence for an intimate relationship. Philos Trans R Soc Lond B Biol Sci. 2011 Jun 27;366(1572):1808-17. doi:10.1098/rstb.2010.0403.

3. Pressman A, Avins AL, Neuhaus J, et al. Adherence to placebo and mortality in the Beta Blocker Evaluation of Survival Trial (BEST). Contemp Clin Trials. 2012 May;33(3):492-8. doi: 10.1016/j.cct.2011.12.003. Epub 2012 Jan 12.

4. Wager TD, Atlas LY. The neuroscience of placebo effects: connecting context, learning and health. Nat Rev Neurosci. 2015 Jul;16(7):403-18. doi: 10.1038/nrn3976.

5. Buchel C, Geuter S, Sprenger C, Eippert F. Placebo analgesia: a predictive coding perspective. Neuron. 2014 Mar 19;81(6):1223-1239. doi: 10.1016/j.neuron.2014.02.042.

6. Hooper R. Quincy's Lexicon-Medicum. A New Medical Dictionary. London; 1811.

7. Beecher HK, Henry K. The Powerful Placebo. J Am Med Assoc. 1955 Dec 24;159(17):1602-6.

8. Manchikanti L, Boswell MV, Kaye AD, et al. Therapeutic Role of Placebo: Evolution of a New Paradigm in Understanding Research and Clinical Practice. Pain Physician. 2017 Jul;20(5):363-386.

9. Colloca L, Enck P, DeGrazia D. Relieving pain using dose-extending placebos: A scoping review. Pain. 2016 Aug;157(8):1590-8. doi: 10.1097/j.pain.0000000000000566.

10. Levine JD, Gordon NC, Fields HL. The mechanism of placebo analgesia. Lancet. 1978 Sep 23;2(8091):654-7.

11. Kennedy WP. The nocebo reaction. Med World. 1961 Sep;95:203-5.

12. Enck P, Benedetti F, Schedlowski M. New insights into the placebo and nocebo responses. Neuron. 2008 Jul 31;59(2):195-206. doi:

13. 1016/j.neuron.2008.06.030.

14. Kam-Hansen S, Jakubowski M, Kelley JM, et al. Altered placebo and drug labelling changes the outcome of episodic migraine attacks. Sci Transl Med. 2014 Jan 8;6(218):218ra5. doi: 10.1126/scitranslmed.3006175.

15. Leuchter AF, Hunter AM, Tartter M, Cook I. A. Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression. Br J Psychiatry. 2014 Dec;205(6):443-9. doi: 10.1192/bjp.bp.113.140343. Epub 2014 Sep 11.

16. Charlesworth JEG, Petkovic G, Kelley JM, et al. Effects of placebos without deception compared with no treatment: A systematic review and meta-analysis. J Evid Based Med. 2017 May;10(2):97-107. doi: 10.1111/jebm.12251.

17. Conrad R. The hardest thing to see is what is in front of your eyes - quo vadis placebo analgesia? J Pain Res. 2016 Oct 14;9:819-823. eCollection 2016.

18. Diener HC, Schorn CF, Bingel U, Dodick DW. The importance of placebo in headache search. Cephalalgia. 2008 Oct;28(10):1003-11. doi: 10.1111/j.1468-2982.2008.01660.x. Epub 2008 Aug 22.

19. Hä user W, Bartram-Wunn E, Bartram C, et al. Systematic review: placebo response in drug trials of fibromyalgia syndrome and painful peripheral diabetic neuropathy- magnitude and patient-related predictors. Pain. 2011 Aug;152(8):1709-17. doi: 10.1016/j.pain.2011.01.050. Epub 2011 Mar 22.

20. Nakamura Y, Donaldson GW, Kuhn R, et al. Investigating dose-dependent effects of placebo analgesia: a psychophysiological approach. Pain. 2012 Jan;153(1):227-37. doi: 10.1016/j.pain.2011.10.024. Epub 2011 Nov 21.

21. Johansen O, Brox J, Flaten MA. Placebo and nocebo responses, cortisol, and circulating -endorphin. Psychosom Med. 2003 Sep- Oct;65(5):786-90.

22. Guo JY, Yuan XY, Sui F, et al. Placebo analgesia affects the behavioral despair tests and hormonal secretions in mice. Psychopharmacology (Berl). 2011 Sep;217(1):83-90. doi: 10.1007/s00213-011-2259-7. Epub 2011 Mar 30.

23. Benedetti F, Lopiano L, Lanotte M, et al. Conscious expectation and unconscious conditioning in analgesic, motor, and hormonal placebo/nocebo responses. J Neurosci. 2003 May 15;23(10):4315-23.

24. Schedlowski M, Pacheco-Lopez G. The learned immune response: Pavlov and beyond. Brain Behav Immun. 2010 Feb;24(2):176-85. doi: 10.1016/j.bbi.2009.08.007. Epub 2009 Aug 19.

25. Kamenica E, Naclerio R, Malani A. Advertisements impact the physiological efficacy of a branded drug. Proc Natl Acad Sci U S A. 2013 Aug 6;110(32):12931-5. doi: 10.1073/pnas.1012818110. Epub 2013 Jul 22.

26. Benedetti F, Durando J, Vighetti S. Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclooxygenaseprostaglandins pathway. Pain. 2014 May;155(5):921-8. doi: 10.1016/j.pain.2014.01.016. Epub 2014 Jan 21.

27. Geuter S, Eippert F, Attar CH, Bü chel C. Cortical and subcortical responses to high and low effective placebo treatments. Neuroimage. 2013 Feb 15;67:227-36. doi: 10.1016/j.neuroimage.2012.11.029. Epub 2012 Nov 28.

28. Yarkoni T, Poldrack RA, Nichols TE, et al. Large-scale automated synthesis of human functional neuroimaging data. Nat Methods. 2011 Jun 26;8(8):665-70. doi: 10.1038/nmeth.1635.

29. Lindquist KA, Wager TD, Kober H, Bliss-Moreau E, Barrett LF. The brain basis of emotion: a meta-analytic review. Behav Brain Sci. 2012 Jun;35(3):121-43. doi: 10.1017/S0140525X11000446.

30. Heinricher M, Fields H, Basbaum A. Central nervous system mechanisms of pain modulation. In: McMahon S, Koltzenburg M, Tracey I, Turk DC, editors. Wall & Melzack's Textbook of Pain. Elsevier Health Sciences; 2013. P. 129-42.

31. Barbas H, Saha S, Rempel-Clower N, Ghashghaei T. Serial pathways from primate prefrontal cortex to autonomic areas may influence emotional expression. BMC Neurosci. 2003 Oct 10;4:25.

32. Wager T, Scott D. Placebo effects on humanopioid activity during pain. Proc Natl Acad Sci U S A. 2007 Jun 26;104(26):11056-61. Epub 2007 Jun 19.

33. Eippert F, Bingel U, Schoell ED, et al. Activation of the opioidergic descending pain control system underlies placebo analgesia. Neuron. 2009 Aug 27;63(4):533-43. doi: 10.1016/j.neuron.2009.07.014.

34. Matre D, Casey KL, Knardahl S. Placeboinduced changes in spinal cord pain processing. J Neurosci. 2006 Jan 11;26(2):559-63.

35. Wager TD, Atlas LY, Leotti LA, Rilling JK. Predicting individual differences in placebo analgesia: contributions of brain activity during anticipation and pain experience. J Neurosci. 2011 Jan 12;31(2):439-52. doi: 10.1523/JNEUROSCI.3420-10.2011.

36. Stein N, Sprenger C, Scholz J, et al. White matter integrity of the descending pain modulatory system is associated with interindividual differences in placebo analgesia. Pain. 2012 Nov;153(11):2210-7. doi: 10.1016/j.pain.2012.07.010. Epub 2012 Sep 5.

37. Geuter S, Koban L, Wager TD. The cognitive neuroscience of placebo effects: concepts predictions, and physiology. Annu Rev Neurosci. 2017 Jul 25;40:167-188. doi: 10.1146/annurevneuro-072116-031132. Epub 2017 Apr 7.

38. Baliki MN, Apkarian AV. Nociception pain, negative moods, and behavior selection. Neuron. 2015 Aug 5;87(3):474-91. doi: 10.1016/j.neuron.2015.06.005.

39. Kisaalita N, Staud R, Hurley R, Robinson M. Placebo use in pain management: the role of medical context treatment efficacy, and deception in determining placebo acceptability. Pain. 2014 Dec;155(12):2638-45. doi: 10.1016/j.pain.2014.09.029. Epub 2014 Sep 28.

40. Лапин ИП. Плацебо и терапия. Санкт-Петербург: Лань; 2000. 224 с. [Lapin IP. Platsebo i terapiya [Placebo and therapy]. Saint-Petersburg: Lan'; 2000. 224 p.]

41. Barrett LF, Simmons WK. Interoceptive predictions in the brain. Nat Rev Neurosci. 2015 Jul;16(7):419-29. doi: 10.1038/nrn3950. Epub 2015 May 28.

42. Geuter S, Boll S, Eippert F, Buchel C. Functional dissociation of stimulus intensity encoding and predictive coding of pain in the insula. Elife. 2017 May 19;6. pii: e24770. doi: 10.7554/eLife.24770.

43. Schafer SM, Geuter S, Wager TD. Mechanisms of placebo analgesia: A dual-process model informed by insights from crossspecies comparisons. Prog Neurobiol. 2018 Jan;160:101-122. doi: 10.1016/j.pneurobio.2017.10.008. Epub 2017 Nov 3.

44. Watson A, El-Deredy W, Bentley DE, et al. Categories of placebo response in the absence of site-specific expectation of analgesia. Pain. 2006 Dec 15;126(1-3):115-22. Epub 2006 Aug 4.

45. Jepma M, Wager TD. Conceptual conditioning: mechanisms mediating conditioning effects on pain. Psychol Sci. 2015 Nov;26(11):1728-39. doi: 10.1177/0956797615597658. Epub 2015 Sep 17.

46. Koban L, Wager TD. Beyond conformity: social influences on pain reports and physiology. Emotion. 2016 Feb;16(1):24-32. doi: 10.1037/emo0000087. Epub 2015 Aug 31.


For citations:

Tabeeva G.R. Placebo analgesia. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):108-115. (In Russ.)

Views: 648

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)